Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma. Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma. Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer." title="" class="btn" data-container="body" data-html="true" data-id="203742" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Hemerion Therapeutics"> 3,352
Activities
Entity types
Location
Lille, France
Lille
France
Employees
Scale: 11-50
Estimated: 16
Engaged catalyst
42Added in Motherbase
1 year, 10 months ago[Automatic translation follows] A new player committed to tackle #glioblastoma and #brain #cancer
Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma.
Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma.
Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.
A new player committed to tackle #glioblastoma and #brain #cancer
Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma.
Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma.
Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.
Advancing cancer therapies with Hemerion Therapeutics' innovative technology to fight brain cancer and glioblastoma.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | Santé publique France | Other 26 Mar 2025 | | |
![]() DECA-BFC Startup accelerator & VC | DECA-BFC Startup accelerator & VC | Other 14 Apr 2024 | | |
![]() | Agence du numérique en santé | Other 30 Nov 2024 | | |
![]() BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Other 5 Dec 2024 | | |
![]() Réseau Entreprendre Alsace Startup accelerator & VC | Réseau Entreprendre Alsace Startup accelerator & VC | Other 24 Mar 2025 | | |
![]() Viva Technology Trade show, IT Services and IT Consulting | Viva Technology Trade show, IT Services and IT Consulting | Other 29 May 2024 | | |
![]() La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 29 May 2024 | | |
![]() Retis Government Administration | Retis Government Administration | Other 12 Apr 2024 | | |
![]() Agence pour la Valorisation de la Recherche Universitaire du Limousin (AVRUL) Research, Research Services | Agence pour la Valorisation de la Recherche Universitaire du Limousin (AVRUL) Research, Research Services | Other 12 Apr 2024 | | |
![]() | Réseau SATT | Other 7 Dec 2024 | |